Its also known as pentadecapeptide BPC-157, PLD-116, PL-10, PL14736 and Bepecin
Cagrilintides amylin receptor targeting, while more focused, has shown remarkable efficacy when combined with other agents, particularly GLP-1 receptor agonists like semaglutide, suggesting potential for combination therapy approaches
In one model, systemic administration of the peptide BPC-157 significantly promoted muscle healing, suggesting its potential to enhance recovery outcomes following muscle injuries
Stability & Half-Life Data Plasma half-life: Very short approximately 5-10 minutes after parenteral administration in rodent pharmacokinetic studies
Research Use Only : This product is sold strictly for research purposes and is not intended for human consumption, therapeutic use, or veterinary applications